title: Evidence from biomarkers and surrogate endpoints.
abstract: The use of physiological, anatomical, and other biological tests is commonplace in the practice of medicine. In neurology, objectively measured tests termed biomarkers (BMs) are playing an increasing role in diagnosis and management of disease, both in clinical practice and in experimental therapeutics. This article will discuss the various applications of BMs to the assessment of therapies for neurological diseases and will use examples from neurological diseases to elucidate the strengths and potential weaknesses of BMs. As the understanding of the pathophysiology of many neurological diseases has improved, new BMs have been developed, and efforts have been made to use these as proxies for clinical endpoints. A BM used in this manner is referred to as a surrogate endpoint (SE). There are many potential advantages and disadvantages of using SEs in the evaluation of new therapies, and these will be reviewed as well. Furthermore, the evidence required for the development of an SE and the nature of the evidence that can be derived from the use of BMs and SEs will be discussed.
authors.affiliation: Center for Neurosciences, North Shore-Long Island Jewish Research Institute, Manhasset, New York 11030, USA. asfeigin@aol.com
authors.forename: Andrew
authors.initials: A
authors.lastname: Feigin
mesh_terms: D000818:Animals; D015415:Biomarkers; D002493:Central Nervous System Diseases / Q000175:diagnosis*; D002986:Clinical Trials as Topic / Q000592:standards; D003937:Diagnosis, Differential; D006801:Humans; D011237:Predictive Value of Tests; D011379:Prognosis; D012107:Research Design / Q000592:standards*
chemical_list: D015415:Biomarkers
references.citation: Neurobiol Aging. 1994 Mar-Apr;15(2):275-6
references.pmid: 7838311
references.citation: J Neurol Neurosurg Psychiatry. 1995 Apr;58(4):496-8
references.pmid: 7738566
references.citation: Arch Neurol. 1995 Aug;52(8):749-53
references.pmid: 7639626
references.citation: Neurology. 1995 Nov;45(11):1995-2004
references.pmid: 7501148
references.citation: Acta Neurol Scand. 1995 Dec;92(6):468-71
references.pmid: 8750112
references.citation: Neurology. 1996 Dec;47(6 Suppl 3):S161-70
references.pmid: 8959985
references.citation: J Neurol Neurosurg Psychiatry. 1996 Dec;61(6):625-7
references.pmid: 8971113
references.citation: Brain. 1997 Dec;120 ( Pt 12):2187-95
references.pmid: 9448574
references.citation: Aust Fam Physician. 1998 Jul;27(7):631-2
references.pmid: 9679387
references.citation: J Neural Transm Suppl. 1999;55:97-102
references.pmid: 10335496
references.citation: JAMA. 1999 Jul 21;282(3):254-60
references.pmid: 10422994
references.citation: Neuroimaging Clin N Am. 1999 Aug;9(3):423-38
references.pmid: 10433636
references.citation: Pacing Clin Electrophysiol. 1999 Jul;22(7):1082-4
references.pmid: 10456638
references.citation: JAMA. 1999 Aug 25;282(8):771-8
references.pmid: 10463714
references.citation: Zhonghua Yi Xue Za Zhi (Taipei). 1999 Sep;62(9):586-90
references.pmid: 10502848
references.citation: Eur J Nucl Med. 1999 Nov;26(11):1413-23
references.pmid: 10552082
references.citation: Arch Neurol. 2000 Feb;57(2):263-7
references.pmid: 10681087
references.citation: Neurobiol Dis. 2000 Aug;7(4):240-50
references.pmid: 10964596
references.citation: Curr Atheroscler Rep. 2000 Mar;2(2):92-6
references.pmid: 11122730
references.citation: Clin Pharmacol Ther. 2001 Mar;69(3):89-95
references.pmid: 11240971
references.citation: Ann Neurol. 2001 Apr;49(4):545-6
references.pmid: 11310639
references.citation: J Nucl Med. 2001 Mar;42(3):408-13
references.pmid: 11337515
references.citation: Biol Signals Recept. 2001 May-Aug;10(3-4):224-53
references.pmid: 11351130
references.citation: J Neurol. 2001 Apr;248(4):271-8
references.pmid: 11374090
references.citation: Am J Manag Care. 2001 May;7(5 Suppl):S144-7
references.pmid: 11383376
references.citation: Ann Neurol. 2001 Jul;50(1):121-7
references.pmid: 11456302
references.citation: Neurology. 2001 Aug 14;57(3):397-404
references.pmid: 11502903
references.citation: Adv Neurol. 2001;86:115-24
references.pmid: 11553968
references.citation: Control Clin Trials. 2001 Oct;22(5):485-502
references.pmid: 11578783
references.citation: JAMA. 2001 Oct 3;286(13):1573-4
references.pmid: 11585466
references.citation: Neurology. 2001 Oct 9;57(7):1222-9
references.pmid: 11591840
references.citation: Folia Neuropathol. 2001;39(1):1-5
references.pmid: 11678345
references.citation: Neuropsychobiology. 2001;44(4):172-5
references.pmid: 11702016
references.citation: Neurology. 2001 Dec 11;57(11):2089-94
references.pmid: 11739831
references.citation: J Epidemiol Community Health. 2002 Feb;56 Suppl 1:i19-24
references.pmid: 11815640
references.citation: Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):493-6
references.pmid: 11828830
references.citation: JAMA. 2002 Apr 3;287(13):1653-61
references.pmid: 11926889
references.citation: Neurology. 2002 Apr 23;58(8 Suppl 4):S23-31
references.pmid: 11971123
references.citation: Semin Roentgenol. 2002 Jul;37(3):212-8
references.pmid: 12226900
references.citation: J Neurosci Res. 2002 Nov 1;70(3):392-401
references.pmid: 12391602
references.citation: Clin Exp Hypertens. 2002 Oct-Nov;24(7-8):669-76
references.pmid: 12450242
references.citation: Mov Disord. 2002 Nov;17(6):1265-70
references.pmid: 12465066
references.citation: Curr Med Chem. 2003 Mar;10(5):349-65
references.pmid: 12570696
references.citation: Ann Neurol. 2003;53 Suppl 3:S26-36; discussion S36-8
references.pmid: 12666096
references.citation: Neurology. 2003 Apr 22;60(8):1234-40
references.pmid: 12707423
references.citation: Neuropsychopharmacology. 2003 Jun;28(6):1182-5
references.pmid: 12700687
references.citation: Clin Pharmacol Ther. 2003 Jun;73(6):481-90
references.pmid: 12811358
references.citation: Ann Neurol. 2003 Jul;54(1):93-101
references.pmid: 12838524
references.citation: Cerebrovasc Dis. 2003;16(3):280-5
references.pmid: 12865617
references.citation: Brain Res Bull. 2003 Aug 15;61(3):243-53
references.pmid: 12909294
references.citation: Curr Neurol Neurosci Rep. 2003 Jul;3(4):314-20
references.pmid: 12930701
references.citation: Neurology. 2003 Sep 9;61(5):596-7
references.pmid: 12963745
references.citation: Mov Disord. 2003 Oct;18 Suppl 7:S63-70
references.pmid: 14531048
references.citation: J Neurol Neurosurg Psychiatry. 2003 Oct;74(10):1447; author reply 1447
references.pmid: 14570850
references.citation: Am J Clin Pathol. 2003 Nov;120(5):672-5
references.pmid: 14608891
references.citation: Stroke. 2003 Dec;34(12):2930-4
references.pmid: 14615618
references.citation: Eur Neurol. 2004;51(1):1-5
references.pmid: 14631121
references.citation: Med J Aust. 1981 Oct 31;2(9):460-5
references.pmid: 6119604
references.citation: J Neuroradiol. 1986;13(1):1-10
references.pmid: 3746435
references.citation: Am Surg. 1987 Feb;53(2):77-9
references.pmid: 3813220
references.citation: Stat Med. 1989 Apr;8(4):431-40
references.pmid: 2727467
references.citation: Arch Neurol. 1989 Oct;46(10):1052-60
references.pmid: 2508608
references.citation: Hosp Community Psychiatry. 1989 Dec;40(12):1310
references.pmid: 2591894
references.citation: Neurology. 1990 Sep;40(9):1337-9
references.pmid: 2118239
references.citation: N Engl J Med. 1991 Mar 21;324(12):781-8
references.pmid: 1900101
references.citation: Neurol Clin. 1992 May;10(2):341-59
references.pmid: 1584178
references.citation: Neurology. 1993 Dec;43(12 Suppl 6):S6-16
references.pmid: 8264913
references.citation: Q J Med. 1994 Feb;87(2):71-3
references.pmid: 8153290
references.citation: J Neurol Neurosurg Psychiatry. 1994 Mar;57(3):278-84
references.pmid: 8158173
references.citation: Lancet. 1994 Jul 16;344(8916):189-90
references.pmid: 7912778
references.citation: Stat Med. 1994 Jul 15-30;13(13-14):1423-35; discussion 1437-40
references.pmid: 7973222